Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03065504 · ClinicalTrials.gov registry record · NA
Turmeric and Turmeric-containing Tablets and Sebum Production
A NA study of Skin Inflammation, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03065504: Completed NA study of Skin Inflammation, sponsored by University of California, Davis.
NCT03065504 is a NA study of Skin Inflammation that has completed, run by University of California, Davis. The registered enrollment target is 30 participants, below the 45-participant average among 4 other Skin Inflammation trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03065504, a NA study of Skin Inflammation, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects of oral turmeric and assess a combination tablet that includes turmeric on sebum production in healthy subjects.
Primary Outcome
The investigators will use Sebutapes placed on the forehead to measure facial sebum production for 60 minutes at baseline and after 4 weeks. The tapes will collect the facial sebum produced during that time.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Turmeric
- DIETARY_SUPPLEMENT Turmeric-containing combination tablet
- DIETARY_SUPPLEMENT Placebo tablets
Study Locations (1)
California
- University of California, Davis Dermatology Clinical Trials Unit - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-08-28 |
| Phase | NA |
What the finished NCT03065504 record still lists
NCT03065504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 45-participant average among 4 other Skin Inflammation trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Skin Inflammation appearing as the primary indexed condition, and to 3 interventions - of which Turmeric is the first listed.
NCT03065504 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03065504 about?
NCT03065504 is a clinical study titled "Turmeric and Turmeric-containing Tablets and Sebum Production". A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects o...
What is the current status of trial NCT03065504?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-11. Estimated completion is 2017-08-28.
What conditions does trial NCT03065504 study?
This clinical trial studies the following conditions: Skin Inflammation.
What interventions are being tested in trial NCT03065504?
The interventions under investigation include: Turmeric (DIETARY_SUPPLEMENT), Turmeric-containing combination tablet (DIETARY_SUPPLEMENT), Placebo tablets (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03065504?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03065504 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
-
Joovvin' for Your Skin Health Study
COMPLETED · NA
-
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
RECRUITING · Phase 2
-
Skin Barrier Function and Inflammation in Aging: The BIA Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia